{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:21:04Z","timestamp":1792480864701,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1136\/ijgc-2020-001584","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T01:54:38Z","timestamp":1595296478000},"page":"1450-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-9441","authenticated-orcid":false,"given":"Roni","family":"Nitecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro T","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-335X","authenticated-orcid":false,"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001584_bb0010","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2020-001584_bb0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001584_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001584_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2020.02.020","article-title":"Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers in phase III randomised trial","volume":"130","author":"Onda","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001584_bb0030","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.18632\/oncotarget.23808","article-title":"The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"9","author":"Qin","year":"2018","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2020-001584_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001584_bb0040","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001584_bb0045","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jmig.2013.04.027","article-title":"Role of minimally invasive surgery in ovarian cancer","volume":"20","author":"Nezhat","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1136\/ijgc-2020-001584_bb0050","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2015.10.922","article-title":"Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-): a feasibility study","volume":"214","author":"Gueli Alletti","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001584_bb0055","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/IGC.0000000000000491","article-title":"Laparoscopic debulking surgery in the management of advanced ovarian cancer after neoadjuvant chemotherapy","volume":"25","author":"Corrado","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001584_bb0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/AOG.0000000000001851","article-title":"Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy","volume":"129","author":"Melamed","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001584_bb0065","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","article-title":"Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Sstudy LAP2","volume":"27","author":"Walker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001584_bb0070","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2017.2068","article-title":"Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage I endometrial cancer: a randomized clinical trial","volume":"317","author":"Janda","year":"2017","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2020-001584_bb0075","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/ijgc-2019-000971","article-title":"Minimally invasive interval cytoreductive surgery: it''s time for a randomized trial","volume":"29","author":"Melamed","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001584_bb0080","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001584_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001584_bb0090","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001584_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/ijgc-2018-000012","article-title":"The International mission study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy","volume":"29","author":"Fagotti","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001584_bb0100","author":"Meigs","year":"1934"},{"key":"10.1136\/ijgc-2020-001584_bb0105","unstructured":"DK Armstrong , RDAlvarez, JNBakkum-Gamez . NCCN clinical practice guideline in oncology: ovarian cancer including fallopian tube cancer and primary peritoneal cancer. version 1.2020. Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf [Accessed 20 Apr 2020].doi:10.1136\/ijgc-2018-00001230640676"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:26:20Z","timestamp":1753233980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1048891X24006728"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001584","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}